These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 17690114)
41. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma. Mainardi S; Mijimolle N; Francoz S; Vicente-Dueñas C; Sánchez-García I; Barbacid M Proc Natl Acad Sci U S A; 2014 Jan; 111(1):255-60. PubMed ID: 24367082 [TBL] [Abstract][Full Text] [Related]
42. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor. Borczuk AC; Sole M; Lu P; Chen J; Wilgus ML; Friedman RA; Albelda SM; Powell CA Cancer Res; 2011 Nov; 71(21):6665-75. PubMed ID: 21911454 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. Lee HY; Suh YA; Lee JI; Hassan KA; Mao L; Force T; Gilbert BE; Jacks T; Kurie JM Clin Cancer Res; 2002 Sep; 8(9):2970-5. PubMed ID: 12231543 [TBL] [Abstract][Full Text] [Related]
44. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. Tran PT; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW PLoS One; 2008 May; 3(5):e2125. PubMed ID: 18461184 [TBL] [Abstract][Full Text] [Related]
45. Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Shaw AT; Meissner A; Dowdle JA; Crowley D; Magendantz M; Ouyang C; Parisi T; Rajagopal J; Blank LJ; Bronson RT; Stone JR; Tuveson DA; Jaenisch R; Jacks T Genes Dev; 2007 Mar; 21(6):694-707. PubMed ID: 17369402 [TBL] [Abstract][Full Text] [Related]
46. How do K-RAS-activated cells evade cellular defense mechanisms? Lee YS; Bae SC Oncogene; 2016 Feb; 35(7):827-32. PubMed ID: 25961920 [TBL] [Abstract][Full Text] [Related]
47. Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Creighton CJ; Bromberg-White JL; Misek DE; Monsma DJ; Brichory F; Kuick R; Giordano TJ; Gao W; Omenn GS; Webb CP; Hanash SM Mol Cancer Res; 2005 Mar; 3(3):119-29. PubMed ID: 15798092 [TBL] [Abstract][Full Text] [Related]
48. DNA mismatch repair deficiency accelerates lung neoplasm development in K-ras(LA1/+) mice: a brief report. Downey CM; Jirik FR Cancer Med; 2015 Jun; 4(6):897-902. PubMed ID: 25773971 [TBL] [Abstract][Full Text] [Related]
49. Lee YS; Lee JY; Song SH; Kim DM; Lee JW; Chi XZ; Ito Y; Bae SC Mol Cells; 2020 Oct; 43(10):889-897. PubMed ID: 33115981 [No Abstract] [Full Text] [Related]
50. Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Iwanaga K; Yang Y; Raso MG; Ma L; Hanna AE; Thilaganathan N; Moghaddam S; Evans CM; Li H; Cai WW; Sato M; Minna JD; Wu H; Creighton CJ; Demayo FJ; Wistuba II; Kurie JM Cancer Res; 2008 Feb; 68(4):1119-27. PubMed ID: 18281487 [TBL] [Abstract][Full Text] [Related]
51. Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma. Sutherland KD; Song JY; Kwon MC; Proost N; Zevenhoven J; Berns A Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4952-7. PubMed ID: 24586047 [TBL] [Abstract][Full Text] [Related]
52. Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Kissil JL; Walmsley MJ; Hanlon L; Haigis KM; Bender Kim CF; Sweet-Cordero A; Eckman MS; Tuveson DA; Capobianco AJ; Tybulewicz VL; Jacks T Cancer Res; 2007 Sep; 67(17):8089-94. PubMed ID: 17804720 [TBL] [Abstract][Full Text] [Related]
53. A quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse models. Haines BB; Bettano KA; Chenard M; Sevilla RS; Ware C; Angagaw MH; Winkelmann CT; Tong C; Reilly JF; Sur C; Zhang W Neoplasia; 2009 Jan; 11(1):39-47. PubMed ID: 19107230 [TBL] [Abstract][Full Text] [Related]
54. Reactive oxygen species and lung tumorigenesis by mutant K-ras: a working hypothesis. Maciag A; Anderson LM Exp Lung Res; 2005; 31(1):83-104. PubMed ID: 15765920 [TBL] [Abstract][Full Text] [Related]
55. Targeting filamin A reduces K-RAS-induced lung adenocarcinomas and endothelial response to tumor growth in mice. Nallapalli RK; Ibrahim MX; Zhou AX; Bandaru S; Sunkara SN; Redfors B; Pazooki D; Zhang Y; Borén J; Cao Y; Bergo MO; Akyürek LM Mol Cancer; 2012 Aug; 11():50. PubMed ID: 22857000 [TBL] [Abstract][Full Text] [Related]
56. Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis. Ghergurovich JM; Esposito M; Chen Z; Wang JZ; Bhatt V; Lan T; White E; Kang Y; Guo JY; Rabinowitz JD Cancer Res; 2020 Sep; 80(18):3820-3829. PubMed ID: 32661137 [TBL] [Abstract][Full Text] [Related]
57. Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer. Kurnit KC; Draisey A; Kazen RC; Chung C; Phan LH; Harvey JB; Feng J; Xie S; Broaddus RR; Bowser JL Cancer Lett; 2021 May; 505():75-86. PubMed ID: 33609609 [TBL] [Abstract][Full Text] [Related]
58. The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras. Ho VM; Schaffer BE; Karnezis AN; Park KS; Sage J Oncogene; 2009 Mar; 28(10):1393-9. PubMed ID: 19151761 [TBL] [Abstract][Full Text] [Related]
59. A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis. Granville CA; Memmott RM; Balogh A; Mariotti J; Kawabata S; Han W; Lopiccolo J; Foley J; Liewehr DJ; Steinberg SM; Fowler DH; Hollander MC; Dennis PA PLoS One; 2009; 4(3):e5061. PubMed ID: 19330036 [TBL] [Abstract][Full Text] [Related]